← FDA Drug Approvals (Drugs@FDA)
ROCURONIUM BROMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL CRITICAL · Approved 2019-08-13
Drug application
- FDA Application #
ANDA210437- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROCURONIUM BROMIDE
- Generic name
- ROCURONIUM
- Active ingredients
- ROCURONIUM BROMIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- PIRAMAL CRITICAL
- Manufacturer
- Piramal Critical Care Inc
- First approval
- 2019-08-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown